Conference Coverage
Conference Coverage
10-year DCIS recurrence risk dwindles with age
Key clinical point: The risk of 10-year recurrence of ductal carcinoma in situ diminishes significantly with age. Major finding: The risk for...
Conference Coverage
Case may be building for annual CA-125 ovarian cancer screening
Key clinical point: Annual CA-125 screening shows trend toward reducing overall mortality from ovarian cancer after 11 years. Major finding: At a...
Conference Coverage
Debulking advanced ovarian cancer to low volume linked with better survival
There is a survival benefit to debulking stage IIIC ovarian, fallopian tube, and peritoneal tumors down to 10 mm or smaller in size, a single-...
Conference Coverage
Trabectedin found to benefit patients with uterine leiomyosarcoma
Among patients with uterine leiomyosarcoma who underwent prior chemotherapy, treatment with trabectedin resulted in superior disease control, with...
Conference Coverage
New data support genetic testing for all ovarian cancer patients
At least one in four ovarian cancer patients has a mutation in a homologous recombination gene.
Conference Coverage
Liquid biopsy detects gynecologic CA recurrence earlier than CT, CA-125
Key clinical point: If tumor DNA is in the blood, cancer is present. Major finding: Following chemotherapy and surgery for gynecologic cancer,...
Conference Coverage
Investigational drug for ovarian, uterine tumors shows promise
A novel dual AKT and P70S6K inhibitor decreased tumor growth metastases in multiple animal models of ovarian and uterine cancer, results from a...
Conference Coverage
Breast density pegged as risk factor for contralateral cancer
Extreme breast density on mammography in women with breast cancer is a strong independent risk factor for in situ or invasive cancer in the...
Conference Coverage
Low phosphate linked to postop infection risk
Phosphate levels following colorectal surgery are predictive of risk for intra-abdominal infections.
Conference Coverage
Exploratory analysis provides support for Recurrence Score
Key clinical point: A commercialized assessment of gene expression, the Recurrence Score, identified high-risk breast cancer patients who could...